FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Przemyslaw Twardowski

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Sumanta K Pal; Junmi Saikia; Cy A Stein; Virginia Sun; Przemyslaw Twardowski; Jonathan Yamzon; Courtney Carmichael; Betty Ferrell; Paul Frankel; Joann Hsu; Kim Margolin
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
James L Mohler; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Stan Rosenfeld; Sandy Srinivas; Seth A Strope; Jonathan Tward; Przemyslaw Twardowski; Patrick C Walsh; Andrew J Armstrong; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas Farrington; Celestia S Higano; Maria Ho; Eric Mark Horwitz; Philip W Kantoff; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R MacVicar; Arnold W Malcolm; David Miller; Dorothy A Shead
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Ari VanderWalde; J Wong; W Ye; Przemyslaw Twardowski; D Asuncion; James Doroshow; Stephen Forman; Paul Frankel; Marianna Koczywas; Lucille Leong; T Luu; Kim Margolin; Robert Morgan; I B Paz; Richard D Pezner; Stephen Shibata; George Somlo
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Przemyslaw Twardowski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sumanta K Pal; Junmi Saikia; Cy A Stein; Virginia Sun; Przemyslaw Twardowski; Jonathan Yamzon; Courtney Carmichael; Betty Ferrell; Paul Frankel; Joann Hsu; Kim Margolin
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
Clinical genitourinary cancer 2013;11(2):121-7.
2012: James L Mohler; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Stan Rosenfeld; Sandy Srinivas; Seth A Strope; Jonathan Tward; Przemyslaw Twardowski; Patrick C Walsh; Andrew J Armstrong; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas Farrington; Celestia S Higano; Maria Ho; Eric Mark Horwitz; Philip W Kantoff; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R MacVicar; Arnold W Malcolm; David Miller; Dorothy A Shead
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(9):1081-7.
2012: Ari VanderWalde; J Wong; W Ye; Przemyslaw Twardowski; D Asuncion; James Doroshow; Stephen Forman; Paul Frankel; Marianna Koczywas; Lucille Leong; T Luu; Kim Margolin; Robert Morgan; I B Paz; Richard D Pezner; Stephen Shibata; George Somlo
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(8):1273-80.
2012: Przemyslaw Twardowski
Re: Twardowski et al.: Phase II study of aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer: a California Cancer Consortium Trial (Urology 2010;76:923-926).
Urology 2012;79(5):1191-2.
2012: J Portnow; Karen Reckamp; Stephen Shibata; Przemyslaw Twardowski; Warren Chow; V Chung; M Cristea; Paul Frankel; S Koehler; Lucille Leong; Dean Lim; C Martel; R Morgan; Timothy W Synold
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;69(2):505-14.
2011: Derek Shek; Przemyslaw Twardowski; Paul Frankel; David R Gandara; Jeff Longmate; Kim A Margolin; Chong-Xian Pan; David I Quinn; Primo Lara
A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma.
International journal of clinical oncology 2011;16(5):494-9.
2010: Przemyslaw Twardowski; Walter M Stadler; Paul Frankel; Primo Lara; Christopher Ruel; Gurkamal Chatta; Elisabeth Iljas Heath; David I Quinn; David R Gandara
Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.
Urology 2010;76(4):923-6.
2010: Robert J Morgan; Timothy W Synold; Adam N Mamelak; Dean Lim; Zaid Al-Kadhimi; Przemyslaw Twardowski; Lucille Leong; Warren Chow; Kim Margolin; Stephen Shibata; George Somlo; Yun Yen; Paul Frankel; James Doroshow
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.
Cancer chemotherapy and pharmacology 2010;66(5):927-33.
2010: Sumanta Kumar Pal; Przemyslaw Twardowski; Oliver Sartor
Critical appraisal of cabazitaxel in the management of advanced prostate cancer.
Clinical interventions in aging 2010;5():395-402.
2009: Sumanta Kumar Pal; Przemyslaw Twardowski; David Y Josephson
Beyond castration and chemotherapy: novel approaches to targeting androgen-driven pathways.
Maturitas 2009;64(2):61-6.
2009: Ashkan Lashkari; Warren A Chow; Frances Valdes; Lucille Leong; Vu Phan; Przemyslaw Twardowski; Neena Kapoor; Arturo Molina; Zaid Al-Kadhimi; Paul Frankel; George Somlo
Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Anticancer research 2009;29(8):3281-8.
2009: Primo Lara; Jeff Longmate; Christopher P Evans; David I Quinn; Przemyslaw Twardowski; Gurkamal Chatta; Edwin Posadas; Walter Stadler; David R Gandara
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
Anti-cancer drugs 2009;20(3):179-84.
2008: Przemyslaw Twardowski; Robert A Figlin
Bevacizumab plus interferon alpha in patients with metastatic renal cell carcinoma.
Nature clinical practice. Oncology 2008;5(8):436-7.
2007: Karen G Chee; Jeff Longmate; David I Quinn; Gurkamal Chatta; Jacek Pinski; Przemyslaw Twardowski; Chong-Xian Pan; Angelo Cambio; Christopher P Evans; David R Gandara; Primo Lara
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.
Clinical genitourinary cancer 2007;5(7):433-7.
2007: James Mohler; Richard J Babaian; Robert R Bahnson; Barry Boston; Anthony V D'Amico; James A Eastham; Ralph J Hauke; Robert P Huben; Philip W Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Chris Logothetis; Gary MacVicar; Alan Pollack; Julio Pow-Sang; Mack Roach; Howard Sandler; Dennis C Shrieve; Sandhya Srinivas; Przemyslaw Twardowski; Donald A Urban; Patrick C Walsh
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Przemyslaw Twardowski; Robert Alan Figlin
What are the indications for sorafenib treatment in patients with renal cell carcinoma?
Nature clinical practice. Oncology 2007;4(8):456-7.
2007: Robert J Morgan; Timothy W Synold; Bixin Xi; Dean Lim; Stephen Shibata; Kim Margolin; Roderich E Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Merry Tetef; Paul Lin; Benjamin Paz; Mariana Koczywas; Lawrence D Wagman; David Chu; Paul Frankel; Susan Stalter; James Doroshow
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(4):1232-7.
2006: Primo Lara; Walter M Stadler; Jeff Longmate; David I Quinn; Jason Wexler; Marta D Van Loan; Przemyslaw Twardowski; Paul H Gumerlock; Nicholas J Vogelzang; Everett E Vokes; Heinz-Josef Lenz; James Doroshow; David R Gandara
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1556-63.
2005: Kim Margolin; James Doroshow; Paul Frankel; Warren Chow; Lucille A Leong; Dean Lim; Mark McNamara; Robert J Morgan; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; Neil Kogut; Jeffrey Schriber; Joseph Alvarnas; Susan Stalter
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):903-11.
2005: Primo Lara; Lisa Y Law; John J Wright; Paul Frankel; Przemyslaw Twardowski; Heinz-Josef Lenz; Derick H Lau; Tomoya Kawaguchi; Paul H Gumerlock; James Doroshow; David R Gandara
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
Anti-cancer drugs 2005;16(3):317-21.
2004: Primo Lara; Przemyslaw Twardowski; David I Quinn
Angiogenesis-targeted therapies in prostate cancer.
Clinical prostate cancer 2004;3(3):165-73.
2004: Warren A Chow; Timothy W Synold; Merry Tetef; Jeff Longmate; Paul Frankel; Joyce Lawrence; Zaid Al-Khadimi; Lucille Leong; Dean Lim; Kim Margolin; Robert J Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Yun Yen; James Doroshow
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Cancer chemotherapy and pharmacology 2004;54(3):241-8.
2004: George Somlo; Paul Frankel; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; Stephen Shibata; Peiguo Chu; Stephen Forman; Dean Lim; Przemyslaw Twardowski; Jeffrey N Weitzel; Joseph Alvarnas; Neil Kogut; Jeffrey Schriber; Eleanor Fermin; Yun Yen; Lloyd Damon; James Doroshow
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1839-48.
2004: Primo Lara; Karen Giselle Chee; Jeff Longmate; Christopher Ruel; Frederick J Meyers; Carl R Gray; Regina Gandour-Edwards; Paul H Gumerlock; Przemyslaw Twardowski; James Doroshow; David R Gandara
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
Cancer 2004;100(10):2125-31.
2004: Glenn Liu; David R Gandara; Primo Lara; Derek Raghavan; James Doroshow; Przemyslaw Twardowski; Philip W Kantoff; William K Oh; KyungMann Kim; George Wilding
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):924-8.
2003: Robert J Morgan; James Doroshow; Timothy W Synold; Dean Lim; Stephen Shibata; Kim Margolin; Roderich Schwarz; Lucille Leong; George Somlo; Przemyslaw Twardowski; Yun Yen; Warren Chow; Paul Lin; Benjamin Paz; David Chu; Paul Frankel; Susan Stalter
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5896-901.
2002: Yun Yen; Warren Chow; Lucille Leong; Kim Margolin; Robert Morgan; James Raschko; Stephen Shibata; George Somlo; Przemyslaw Twardowski; Paul Frankel; Jeff Longmate; Timothy W Synold; Edward M Newman; Heinz-Josef Lenz; David R Gandara; James Doroshow
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial.
Cancer chemotherapy and pharmacology 2002;50(5):353-9.
2002: Primo Lara; Frederick J Meyers; Carl R Gray; Regina Gandour-Edwards; Paul H Gumerlock; Caren Kauderer; Garrett Tichauer; Przemyslaw Twardowski; James Doroshow; David R Gandara
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.
Cancer 2002;94(10):2584-9.